Evidence map›Paper›PMID 33807480›Full record

ArticleMaterials (Basel, Switzerland)2021

Multilayered Porous Titanium-Based 3rd Generation Biomaterial Designed for Endosseous Implants.

George Calin Dindelegan, Alexandra Caziuc, Ioana Brie, Olga Soritau, Maximilian George Dindelegan, Vasile Bintintan, Violeta Pascalau, Carmen Mihu, Catalin Popa

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

George Calin DindeleganSurgical Department, University of Medicine and Pharmacy "Iuliu Hatieganu", 400349 Cluj-Napoca, Romania.
Alexandra CaziucSurgical Department, University of Medicine and Pharmacy "Iuliu Hatieganu", 400349 Cluj-Napoca, Romania.
Ioana BrieRadiobiology and Tumor Biology Department, Oncologic Institute Ion Chiricuta, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-6915-3636
Olga SoritauRadiobiology and Tumor Biology Department, Oncologic Institute Ion Chiricuta, 400015 Cluj-Napoca, Romania.
Maximilian George DindeleganENT Department, University of Medicine and Pharmacy "Iuliu Hatieganu", 400349 Cluj-Napoca, Romania.ORCID 0000-0002-4334-0967
Vasile BintintanSurgical Department, University of Medicine and Pharmacy "Iuliu Hatieganu", 400349 Cluj-Napoca, Romania.ORCID 0000-0002-1435-6791
Violeta PascalauDepartment of Science and Technology, Faculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania.
Carmen MihuHistology Department, University of Medicine and Pharmacy "Iuliu Hatieganu", 400349 Cluj-Napoca, Romania.
Catalin PopaDepartment of Science and Technology, Faculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · ROTechnical University of Cluj-Napoca · RO

Funding

Ministry of Education PN-II-PT-PCCA-2011-3.1-0700
6 · The paper itself

Abstract

This work proposes a novel complex multi-layered material consisting of porous titanium as a substrate and a complex coating consisting of a chitosan film engulfing microsphere loaded with growth factors such as BMP2 (bone morphogenic protein 2) and IGF1 (insulin-like growth factor-1). The microspheres were obtained through deposition of dual layers of calcium cross linked pectin-chitosan/pectin polyelectrolyte onto a BSA (bovine serum albumin) gel core. The multilayer was conceived to behave like a 3rd generation biomaterial, by slow delivery of viable growth factors around implants, and to assist the healing of implantation wound and the development of new vital bone. The biologic effect of the delivery of growth factors was studied in vitro, on MSC-CD1 mesenchymal stem cells, and in vivo, on CD1 mice. Proliferation and differentiation of cells were accelerated by growth factors, especially IGF1 for proliferation and BMP2 for differentiation. In vivo tests analyzed histologically and by MicroCT show a more structured tissue around BMP2 samples. The present concept will give the best clinical results if both growth factors are delivered together by a coating film that contains a double population of microcarriers.

Indexed as

biomaterialBMP2growth factorsIGF1microspherestitanium

Identifiers

PMID33807480
PMCPMC8036277
OpenAlexW3143730547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.